A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital


  • Shruti Vihang Brahmbhatt Department of Pharmacology, SBKS MI & RC, Sumandeep Vidyapeeth, Piapria, Vadodara, Gujarat, India
  • Bhagya M. Sattigeri Department of Pharmacology, SBKS MI & RC, Sumandeep Vidyapeeth, Piapria, Vadodara, Gujarat, India




ACE inhibitors, Angiotensin receptor blockers, β1 blockers, Calcium channel blockers, Drug utilization


Background: This study was aimed to analyze the drug utilization pattern in the management of hypertension in diabetic patients.

Methods: A prospective, observational and non interventional study was conducted in 100 diabetic hypertensive patients admitted in medicine wards at Dhiraj Hospital. Patients who signed informed consent form were only included in the study. All the data were recorded from patients’ case files and analyzed.

Results: Of enrolled 100 patients, 69 (69%) were male and 31 (31%) were female and maximum number of the patients (42%) were found in the age group of 51-60 years. Out of 100 admitted patients, 75% patients were treated with single antihypertensive agent, 20% were treated with combination of two antihypertensive agents while only 5% were administered more than two antihypertensive agents. As a single antihypertensive agent, most commonly prescribed was ACE inhibitors (32%), Calcium Channel Blockers (23%), Angiotensin Receptor Blockers (12%) and β1 blockers (8%).

Conclusions: There was poor awareness among the patients regarding control of hypertension, regular follow up, medication adherence etc. However, two third of diabetic patients had achieved blood pressure target control and ACE inhibitor remained first choice of drug for hypertension in diabetes in this study.


Joshi SR. Management of obese Indian patient. Indian J Obesity. 2005;i(1):11-20.

Mohan V, Deepa M, Farooq S, Datta M, Deepa R. Prevalence, awareness and control of hypertension in chennai–the chennai urban rural epidemiology study (cures-52). J Assoc Physicians Ind. 2007;55:326-32.

Yadav S, Boddula R, Genitta G, Bhatia V, Bansal B, Kongara S, et al. Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population. Ind J Med Reseae. 2008 Dec 1;128(6).

Gupta R. Trends in hypertension epidemiology in india. J Hum Hypertens. 2004;18:73-8.

Gupta R, Gupta S, Gupta VP, Prakash H. Prevalence and determinants of hypertension in the urban population of Jaipur in western India. J Hypertens. 1995;13:1193-200.

Anand MP. Prevalence of hypertension amongst Mumbai executives. J Assoc Physicians India 2000;48:1200-1.

Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. High prevalence of diabetes and impaired glucose tolerance in India: National urban diabetes survey. Diabetologia. 2001;44:1094-101.

Beckman JA, Crenger MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-81.

Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, et al. Report of the national heart, lung, and blood institute: National institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus. Circulation. 2005;111:3489-93.

Sowers JR, Epstein M, Frolich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053-9.

Stults B, Jones RE. Management of hypertension in diabetes. Diabetes Spectrum. 2006;19(1):25-31.

Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-Dehoff R, et al. Clinical outcomes in the diabetic cohort of the international Verapamil SR Trandolapril study. Hypertension. 2004;44:643-8.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan diabetic nephropathy trial. J Am Soc Nephrol. 2005;16:2170-9.

Williams B, Poulter NR, Brown MJ, Davis M, Mcinnes GT, Potter JF, et al. Guidelines for the management of hypertension: report of the fourth working party of the British hypertension society, 2004. J Human Hypertens. 2004;18:139-85.

European societies of hypertension and cardiology. Guidelines for the management of arterial hypertension, 2003. J Hypertens. 2003;21:1011-52.

Majernick TG, Zacker C, Madden NA, Belletti DA, Arcona S. Correlates of hypertension control in a primary care setting. Am J Hypertens. 2004;17:915-20.

Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Palmer CR, Rosenthal T, et al. Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension. 2000;35:1038-42.

Shah A, Afzal M. Prevalence of diabetes and hypertension and association with various risk factors among different muslim populations of Manipur, India. Journal of Diabetes and Metabolic Disorders. 2013;12:52.

Brahmbhatt SV, Sattigeri BM, Nil AK, Parikh DP, Shah HS, A prospective study on drug utilization pattern and rationality in treatment of type II diabetes mellitus: a population based analysis. Int J Res Med Sci. 2014;2:983-7.

Konzem SL. Controlling Hypertension in Patients with Diabetes. American Family Physician. 2002;66(7).

Rachana PR, Anuradha HV. Anti hypertensive prescribing patterns and cost analysis for primary hypertension: a retrospective study. Journal of clinical and diagnostic research: JCDR. 2014 Sep;8(9):HC19.

Datta S. Utilization Study of Antihypertensives in a South Indian Tertiary Care Teaching Hospital and Adherence to Standard Treatment Guidelines. J Basic Clin Pharma. 2017;8:33-7.

Beg MA, Dutta S, Varma A, Kant R, Bawa S, Anjoom M, et al. A study on drug prescribing pattern in hypertensive patients in a tertiary care teaching hospital at Dehradun, Uttarakhand. Int J Med Sci Public Health. 2014;3:922-6.

Ganguly SS, Shafaee MA, Bhargava K, Duttagupta KK. Prevalence of prehypertension and associated cardiovascular risk profiles among Omani adults. BMC Public Health. 2008;8:108.

White F, Wang L, Jelinek HF. Management of hypertension in patients with diabetes mellitus. Exp Clin Cardiol. 2010;15(1):5-8.

Robert H, Fagard. Smoking amplifies cardiovascular risk in patients with hypertension and diabetes. Diabetes Care. 2009;32(suppl 2):s429-s431.

Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ. 2000;321:412-9.

Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: Blood Pressure goals, choice of agents, and setting priorities in diabetes care. Annals of Internal Medicine. 2003;138(7):593-603.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-Based Guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.

Messerli FH, Grossman E, Leonetti G. Antihypertensive therapy and new onset diabetes. J Hypertens. 2004;22:1845-7.

Standl E, Erbach, Schnell O. What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and Cons. Diabetes Metab Res Rev. 2012;28(Suppl 2):60-6.




How to Cite

Brahmbhatt, S. V., & Sattigeri, B. M. (2018). A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital. International Journal of Basic & Clinical Pharmacology, 7(11), 2196–2200. https://doi.org/10.18203/2319-2003.ijbcp20184327



Original Research Articles